165 related articles for article (PubMed ID: 1907901)
1. Post-cardiac transplant reactivation of Chagas' disease diagnosed by skin biopsy.
Libow LF; Beltrani VP; Silvers DN; Grossman ME
Cutis; 1991 Jul; 48(1):37-40. PubMed ID: 1907901
[TBL] [Abstract][Full Text] [Related]
2. Chagas' disease reactivation with skin symptoms in a patient with kidney transplant.
Gallerano V; Consigli J; Pereyra S; Gómez Zanni S; Danielo C; Gallerano RH; Guidi A
Int J Dermatol; 2007 Jun; 46(6):607-10. PubMed ID: 17550560
[TBL] [Abstract][Full Text] [Related]
3. Heart transplantation for Chagas' cardiomyopathy.
Blanche C; Aleksic I; Takkenberg JJ; Czer LS; Fishbein MC; Trento A
Ann Thorac Surg; 1995 Nov; 60(5):1406-8; discussion 1408-9. PubMed ID: 8526639
[TBL] [Abstract][Full Text] [Related]
4. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment.
Almeida DR; Carvalho AC; Branco JN; Pereira AP; Correa L; Vianna PV; Buffolo E; Martinez EE
J Heart Lung Transplant; 1996 Oct; 15(10):988-92. PubMed ID: 8913915
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous manifestation of Chagas' disease after heart transplantation: successful treatment with allopurinol.
Tomimori-Yamashita J; Deps PD; Almeida DR; Enokihara MM; De Seixas MT; Freymüller E
Br J Dermatol; 1997 Oct; 137(4):626-30. PubMed ID: 9390344
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for Chagas' disease reactivation after heart transplantation.
Campos SV; Strabelli TM; Amato Neto V; Silva CP; Bacal F; Bocchi EA; Stolf NA
J Heart Lung Transplant; 2008 Jun; 27(6):597-602. PubMed ID: 18503957
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients.
Riganti J; Maqueda MG; Piñero MC; Volonteri VI; Galimberti RL
Int J Dermatol; 2012 Jul; 51(7):829-34. PubMed ID: 22715827
[TBL] [Abstract][Full Text] [Related]
8. Transplantation for Chagas' disease: an overview of immunosuppression and reactivation in the last two decades.
Bacal F; Silva CP; Pires PV; Mangini S; Fiorelli AI; Stolf NG; Bocchi EA
Clin Transplant; 2010; 24(2):E29-34. PubMed ID: 20088914
[TBL] [Abstract][Full Text] [Related]
9. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
[TBL] [Abstract][Full Text] [Related]
10. [Erythema nodoso in reactivation of Chagas' disease after cardiac transplantation].
d'Avila SC; d'Avila AM; Pagliari C; Gonçalves VM; Duarte MI
Rev Soc Bras Med Trop; 2005; 38(1):61-3. PubMed ID: 15717098
[TBL] [Abstract][Full Text] [Related]
11. Late reactivation of Chagas' disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy.
Marchiori PE; Alexandre PL; Britto N; Patzina RA; Fiorelli AA; Lucato LT; Rosemberg S; Pereira SL; Stolf NG; Scaff M
J Heart Lung Transplant; 2007 Nov; 26(11):1091-6. PubMed ID: 18022073
[TBL] [Abstract][Full Text] [Related]
12. Heart transplantation in patients with Chagas' disease cardiomyopathy.
Stolf NA; Higushi L; Bocchi E; Bellotti G; Auler JO; Uip D; Amato Neto V; Pileggi F; Jatene AD
J Heart Transplant; 1987; 6(5):307-12. PubMed ID: 3316557
[TBL] [Abstract][Full Text] [Related]
13. Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation.
Maldonado C; Albano S; Vettorazzi L; Salomone O; Zlocowski JC; Abiega C; Amuchastegui M; Córdoba R; Alvarellos T
J Heart Lung Transplant; 2004 Dec; 23(12):1345-8. PubMed ID: 15607662
[TBL] [Abstract][Full Text] [Related]
14. [Nifurtimox as a prophylactic drug to prevent reactivation in chronic chagasic patients treated with corticoid for associated diseases].
Rassi A; Neto VA; de Siqueira AF; Leite MS
Rev Soc Bras Med Trop; 1998; 31(3):249-55. PubMed ID: 9612015
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous manifestation of reactivation of Chagas disease in a renal transplant patient: long-term follow-up.
La Forgia MP; Pellerano G; de las Mercedes Portaluppi M; Kien MC; Chouela EN
Arch Dermatol; 2003 Jan; 139(1):104-5. PubMed ID: 12533185
[No Abstract] [Full Text] [Related]
16. [Cutaneous lesions as the only manifestations of reactions to Trypanosoma cruzi infection in a recipient of a kidney transplant].
Amato JG; Amato Neto V; Amato VS; Duarte MI; Uip DE; Boulos M
Rev Soc Bras Med Trop; 1997; 30(1):61-3. PubMed ID: 9026833
[TBL] [Abstract][Full Text] [Related]
17. [Using S35-S36 and TcH2AF-R primer-based PCR tests to follow-up a Chagas´ disease patient who had undergone a heart transplant].
Pavía PX; Roa NL; Uribe AM; Puerta CJ
Biomedica; 2011 Jun; 31(2):178-84. PubMed ID: 22159533
[TBL] [Abstract][Full Text] [Related]
18. Heart transplants for patients with Chagas' heart disease.
Bocchi EA
Sao Paulo Med J; 1995; 113(2):873-9. PubMed ID: 8650490
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil blood count and anemia are associated with Trypanosoma cruzi infection reactivation in Chagas' heart transplant recipients.
Theodoropoulos TA; Silva AG; Bestetti RB
Int J Cardiol; 2010 Nov; 145(1):55-6. PubMed ID: 19419778
[TBL] [Abstract][Full Text] [Related]
20. [Current prospects of specific treatment of Chagas' disease].
Coura JR
Bol Chil Parasitol; 1996; 51(3-4):69-75. PubMed ID: 9302778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
